National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 103844 [2024-30080]
Download as PDF
<![CDATA[
103844
Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meetings of the Advisory Committee
on Training and Primary Care Medicine
and Dentistry (ACTPCMD)
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Training in Primary Care
Medicine and Dentistry (ACTPCMD or
Committee) will hold public meetings
for the 2025 calendar year (CY).
Information about ACTPCMD, agendas,
and materials for these meetings can be
found on the ACTPCMD website at:
https://www.hrsa.gov/advisorycommittees/primarycare-dentist.
DATES: ACTPCMD meetings will be held
on
• March 27, 2025, 8 a.m.–5 p.m. Eastern
Time (ET) and March 28, 2025, 8
a.m.–2 p.m. ET
• August 8, 2025, 10 a.m.–5 p.m. ET
ADDRESSES: Meetings will be held inperson, by teleconference, and/or on a
video conference platform. In-person
meetings will be held at 5600 Fishers
Lane, Rockville, Maryland, 20857. For
updates on how the meetings will be
held, instructions for joining the
meeting, or any other updates, visit the
ACTPCMD website 30 business days
before the date of the meeting, at:
https://www.hrsa.gov/advisorycommittees/primarycare-dentist/
meetings.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
Shane Rogers, Designated Federal
Officer, Division of Medicine and
Dentistry, Bureau of Health Workforce,
HRSA, 5600 Fishers Lane, Room
15N102, Rockville, Maryland, 20857;
301–443–5260; or SRogers@hrsa.gov.
SUPPLEMENTARY INFORMATION:
ACTPCMD provides advice and
recommendations on policy and
program development and other matters
of significance to the Secretary of of
Health and Human Services (Secretary)
concerning the medicine and dentistry
activities authorized under section 747
of the Public Health Service (PHS) Act,
as it existed upon the enactment of
Section 749 of the PHS Act in 1998, and
is responsible for preparing and
submitting an annual report to the
Secretary and Congress describing the
activities of the Committee, including
VerDate Sep<11>2014
18:08 Dec 18, 2024
Jkt 265001
findings and recommendations made by
the Committee concerning activities
authorized under section 747 of the PHS
Act, as it existed upon the enactment of
Section 749 of the PHS Act in 1998. In
addition, ACTPCMD develops,
publishes, and implements performance
measures and guidelines for
longitudinal evaluations for programs
authorized under Part C of Title VII of
the PHS Act, as well as recommends
appropriation levels for programs under
this part.
Since priorities dictate meeting times,
be advised that start times, end times,
and agenda items are subject to change.
For CY 2025 meetings, agenda items
may include, but are not limited to:
pathways, recruitment, and retention of
American Indian health providers;
health workforce diversity; community
colleges; faculty shortages; and dental
accreditation requirements; as well as
discussions pertaining to policy,
program development, and other
matters of significance concerning
medicine and dentistry activities
authorized under the relevant sections
of the PHS Act. Refer to the ACTPCMD
website listed above for all current and
updated information concerning the CY
2025 ACTPCMD meetings, including
agendas and meeting materials that will
be posted 30 calendar days before the
meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting(s). Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to ACTPCMD
should be sent to Shane Rogers using
the contact information above at least 5
business days before the meeting
date(s).
Individuals who need special
assistance or another reasonable
accommodation should notify Shane
Rogers using the contact information
listed above at least 10 business days
before the meeting(s) they wish to
attend. Since all in-person meetings will
occur in a federal government building
at 5600 Fishers Lane, Rockville, MD,
20857, attendees must go through a
security check to enter the building.
Members of the public must notify the
Designated Federal Officer of their
intent to attend the in-person meeting
10 business days before the meeting.
Non-U.S. citizen attendees must notify
the Designated Federal Officer of their
planned attendance at least 20 business
days prior to the meeting to facilitate
their entry into the building. All
attendees are required to present
PO 00000
Frm 00081
Fmt 4703
Sfmt 9990
government-issued identification prior
to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–30073 Filed 12–18–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 NCBIB Review
G–SEP.
Date: February 11–13, 2025.
Time: 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, Suite 920, 6707 Democracy
Blvd., Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Yoon-Young Jang, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Bethesda, MD 20892, (301)
451–3397, yoonyoung.jang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: December 13, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30080 Filed 12–18–24; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 89, Number 244 (Thursday, December 19, 2024)]
[Notices]
[Page 103844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30080]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting of the
National Institute of Biomedical Imaging and Bioengineering Special
Emphasis Panel.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; P41 NCBIB Review G-SEP.
Date: February 11-13, 2025.
Time: 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy II, Suite 920,
6707 Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Yoon-Young Jang, Ph.D., Scientific Review
Officer, National Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health, 6707 Democracy Blvd.,
Bethesda, MD 20892, (301) 451-3397, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: December 13, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-30080 Filed 12-18-24; 8:45 am]
BILLING CODE 4140-01-P
